Brooks Moore & Associates’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $458K | Sell |
4,157
-338
| -8% | -$37.2K | 0.25% | 75 |
|
|
2025
Q1 | $455K | Hold |
4,495
| – | – | 0.26% | 75 |
|
|
2024
Q4 | $415K | Hold |
4,495
| – | – | 0.25% | 72 |
|
|
2024
Q3 | $434K | Hold |
4,495
| – | – | 0.26% | 71 |
|
|
2024
Q2 | $386K | Hold |
4,495
| – | – | 0.25% | 70 |
|
|
2024
Q1 | $371K | Sell |
4,495
-60
| -1% | -$4.96K | 0.24% | 71 |
|
|
2023
Q4 | $304K | Hold |
4,555
| – | – | 0.21% | 69 |
|
|
2023
Q3 | $306K | Hold |
4,555
| – | – | 0.23% | 67 |
|
|
2023
Q2 | $308K | Hold |
4,555
| – | – | 0.22% | 69 |
|
|
2023
Q1 | $246K | Hold |
4,555
| – | – | 0.18% | 77 |
|
|
2022
Q4 | $272K | Hold |
4,555
| – | – | 0.2% | 77 |
|
|
2022
Q3 | $206K | Sell |
4,555
-1,171
| -20% | -$53K | 0.17% | 80 |
|
|
2022
Q2 | $255K | Hold |
5,726
| – | – | 0.18% | 78 |
|
|
2022
Q1 | $324K | Sell |
5,726
-14,543
| -72% | -$823K | 0.2% | 78 |
|
|
2021
Q4 | $1.05M | Buy |
20,269
+14,041
| +225% | +$729K | 0.62% | 45 |
|
|
2021
Q3 | $372K | Hold |
6,228
| – | – | 0.24% | 74 |
|
|
2021
Q2 | $387K | Hold |
6,228
| – | – | 0.25% | 75 |
|
|
2021
Q1 | $406K | Sell |
6,228
-965
| -13% | -$62.9K | 0.28% | 72 |
|
|
2020
Q4 | $473K | Hold |
7,193
| – | – | 0.37% | 66 |
|
|
2020
Q3 | $372K | Hold |
7,193
| – | – | 0.32% | 66 |
|
|
2020
Q2 | $354K | Hold |
7,193
| – | – | 0.33% | 68 |
|
|
2020
Q1 | $366K | Hold |
7,193
| – | – | 0.39% | 69 |
|
|
2019
Q4 | $396K | Hold |
7,193
| – | – | 0.31% | 74 |
|
|
2019
Q3 | $362K | Hold |
7,193
| – | – | 0.31% | 76 |
|
|
2019
Q2 | $363K | Hold |
7,193
| – | – | 0.31% | 78 |
|
|
2019
Q1 | $334K | Sell |
7,193
-71
| -1% | -$3.3K | 0.3% | 75 |
|
|
2018
Q4 | $357K | Buy |
+7,264
| New | +$357K | 0.36% | 67 |
|